Importantly, and emphasizing acute (fast‐acting) roles of IFN responses, we validated an over 1,000‐fold induction of IFNB1 4h after treatment in HLEC with similar kinetics than for melanoma cells (Fig 5A). The gene discussed is IFNB1; the disease is melanoma.